Dr Aradhana Sarin steps in as CFO at AstraZeneca

British-Swedish multinational pharmaceutical firm AstraZeneca has announced the appointment of Dr Aradhana Sarin as an Executive Director and Chief Financial Officer (CFO), following the closing of AstraZeneca’s acquisition of Alexion Pharmaceuticals, Inc. Dr Aradhana was serving as the Executive VicePresident, Chief Financial Officer of Alexion. She will relocate from the US and be based in the UK. She will report to AstraZeneca’s Chief Executive Officer, Pascal Soriot. Dr Aradhana will succeed Marc Dunoyer who will step down as CFO and retire from AstraZeneca’s Board, having served as CFO for over seven years. She has more than 20 years of professional experience spanning operating roles at Alexion and advisory roles at global financial institutions, gaining extensive knowledge of global healthcare systems, capital markets and strategic transactions. Prior to joining Alexion, she was Managing Director, Healthcare Corporate & Investment Banking, Citi Global Banking in New York where she advised clients in the life sciences and biopharmaceutical sectors.